Flexion Therapeutics to Present at the BMO 2020 Prescriptions for Success Healthcare Conference
June 16 2020 - 3:30PM
Flexion Therapeutics, Inc. (Nasdaq:FLXN) announced today that
Michael Clayman, M.D., President and Chief Executive Officer, will
participate in an analyst-led fireside chat at the BMO 2020
Prescriptions for Success Healthcare Conference. The virtual
fireside chat is scheduled to begin at 9:30 a.m. ET on
Tuesday, June 23, 2020.
To access the live webcast of the presentation, please visit the
Flexion website at http://ir.flexiontherapeutics.com.
About Flexion Therapeutics Flexion Therapeutics
(Nasdaq:FLXN) is a biopharmaceutical company focused on the
development and commercialization of novel, local therapies for the
treatment of people with musculoskeletal conditions, beginning with
osteoarthritis, the most common form of arthritis. The Company's
core values are focus, ingenuity, tenacity, transparency and fun.
Visit flexiontherapeutics.com.
Contact:
Scott YoungVice President, Corporate Communications &
Investor RelationsFlexion Therapeutics, Inc.T:
781-305-7194syoung@flexiontherapeutics.com
Flexion Therapeutics (NASDAQ:FLXN)
Historical Stock Chart
From Apr 2024 to May 2024
Flexion Therapeutics (NASDAQ:FLXN)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about Flexion Therapeutics Inc (NASDAQ): 0 recent articles
More News Articles